RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)
CUSIP: 75955J402
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock ($.001 par value)
- Shares outstanding
- 74,702,121
- Total 13F shares
- 10,506,228
- Share change
- +1,150,045
- Total reported value
- $469,323,200
- Put/Call ratio
- 4.7%
- Price per share
- $44.75
- Number of holders
- 74
- Value change
- +$57,833,259
- Number of buys
- 59
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75955J402:
Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.8%
|
1,379,988
|
$47,071,000 | — | 31 Mar 2020 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,300,000
|
$44,343,000 | — | 31 Mar 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.5%
|
1,150,000
|
$39,227,000 | — | 31 Mar 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.3%
|
984,542
|
$33,583,000 | — | 31 Mar 2020 | |
| VR Adviser, LLC |
13F
|
Company |
1.1%
|
842,814
|
$28,748,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.78%
|
579,858
|
$19,779,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.64%
|
478,013
|
$16,304,000 | — | 31 Mar 2020 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.57%
|
425,575
|
$14,516,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.43%
|
320,072
|
$10,918,000 | — | 31 Mar 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.4%
|
300,000
|
$10,233,000 | — | 31 Mar 2020 | |
| TIEDEMANN ADVISORS, LLC |
13F
|
Company |
0.38%
|
282,592
|
$9,639,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.36%
|
266,118
|
$9,077,000 | — | 31 Mar 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.3%
|
225,000
|
$7,675,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
107,689
|
$3,673,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
106,245
|
$3,624,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
98,144
|
$3,348,000 | — | 31 Mar 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.12%
|
90,950
|
$3,102,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
83,566
|
$2,850,000 | — | 31 Mar 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.07%
|
55,172
|
$1,882,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
53,328
|
$1,820,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
38,423
|
$1,311,000 | — | 31 Mar 2020 | |
| MEYER HANDELMAN CO |
13F
|
Company |
0.04%
|
28,378
|
$968,000 | — | 31 Mar 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
28,252
|
$964,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
26,613
|
$908,000 | — | 31 Mar 2020 | |
| World Investment Advisors |
13F
|
Company |
0.02%
|
14,000
|
$478,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
13,962
|
$476,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
11,685
|
$399,000 | — | 31 Mar 2020 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.01%
|
11,000
|
$375,000 | — | 31 Mar 2020 | |
| CHARTWELL INVESTMENT PARTNERS, LLC |
13F
|
Company |
0.01%
|
9,482
|
$323,000 | — | 31 Mar 2020 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
9,225
|
$315,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
8,400
|
$287,000 | — | 31 Mar 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
7,936
|
$271,000 | — | 31 Mar 2020 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0.01%
|
6,000
|
$205,000 | — | 31 Mar 2020 | |
| Tortoise Investment Management, LLC |
13F
|
Company |
0.01%
|
3,835
|
$131,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,043
|
$104,000 | — | 31 Mar 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
2,876
|
$98,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,700
|
$58,000 | — | 31 Mar 2020 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
900
|
$30,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
776
|
$26,000 | — | 31 Mar 2020 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
525
|
$17,000 | — | 31 Mar 2020 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
306
|
$10,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
75
|
$3,000 | — | 31 Mar 2020 | |
| Glen Eagle Advisors, LLC |
13F
|
Company |
0%
|
25
|
$853 | — | 31 Mar 2020 |
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2020
As of 30 Jun 2020,
RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,506,228 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, VR Adviser, LLC, TANG CAPITAL MANAGEMENT LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Invesco Ltd., and BOXER CAPITAL, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
43
Q2 2020 holders
74
Holder diff
31
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.